Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Pevion Biotech" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Pevion Biotech for you to read. Along with our medical data and news we also list Pevion Biotech Clinical Trials, which are updated daily. BioPortfolio also has a large database of Pevion Biotech Companies for you to search.
With a massive €530M ($604M) raised, US-based Moderna has made a record biotech IPO. The news could give a significant boost to developers of messenger RNA, a technology that is still several years away from the market. Entering the Nasdaq ... The post What Does the Largest Biotech IPO Ever Mean for European Biotech? appeared first on Labiotech.eu.
Ian Nicholson, CEO of F2G, updated Mike Ward during Biotech Showcase 2019 on the progress the biotech company is having...
Oslo, 13 September 2018. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and ...
Joe Dupere, CEO at Rexgenero, reveals to Mike Ward during Biotech Showcase 2019 the four-year-old UK biotech’s plans.
FIT Biotech Oy Company release 7.1.2019 at 9:55 EET Changes in FIT Biotech’s Board of Directors FIT Biotech Oy’s (“Company”, FITBIO: FN Finland) Chairman of the Board of Directors, Doctor Chitra Bharucha has resigned from Board of Directors for medical reasons. … Continue reading →
Over the last two weeks, several biotech companies in Europe have decided to postpone IPOs on the stock markets — is this a sign that biotech stocks are underperforming? Since the end of October, several European biotech companies have ... The post Are Recent IPO Delays Bad News for European Biotech? appeared first on Labiotech.eu.
As Sweden’s capital, Stockholm is perhaps best known for its picturesque islands and bridges, crayfish festivals, and wondrously preserved medieval architecture, but the city is also a hub of biotech enterprise. Stockholm’s biotech industry is particularly strong when it comes ... The post The Top 10 Biotech Companies in Stockholm appeared first on Labiotech.eu.
Scientists at the University of California at Davis are developing biotech cattle that do not grow horns and biotech cows tha -More-
Early stage biotech companies and scientists interested in commercialization need great accelerator programs, not more biotech incubators. Biotech companies and scientists who start out on the road to commercialization may need an accelerator to bring out the entrepreneurial spirit. The incubator and accelerator models are conflated all the time in biotech, much to the fury […] The post Acce...
Is the next big idea in oncology a bust? What does "successful" mean, exactly? And why does Wall Street hate biotech all of a sudden? Find out on our biotech…
Last year was a remarkable year for biotech companies going public. Not only did an unusually large number of biotech companies go public, but a significant number of early-stage biotech companies went public at premium valuations relative to their later-clinical stage peers. There were approximately 58 biotech IPOs in 2018 (excluding offerings with under $25 […]
There’s just one week left until Xconomy’s latest biotech event, “San Francisco Biotech: The Next Generation.” Don’t let the clock run out while you can still save some cash on a ticket. Next Wednesday, Dec. 5, company founders and visionary scientists will share how they are pursuing new ideas and breaking biotech boundaries. Don’t wait […]
A STAT-curated preview of biotech events and issues that we believe will grab headlines and attention in biotech over the next 12 months.
While major biotech indices went south in 2018, VC enthusiasm for biotech remained bullish. Biotech companies raised a record $22.83bn...
Royal DSM-owned Biotech Campus Delft, together with YES!Delft, has created the Biotech Validation Lab to support European sta -More-
This year has been a strong one for biotech initial public offerings (IPO). According to the Wall Street Journal, as of mid-October, 55 biotech companies had raised $5.75 billion.
Biotech startups are a high-risk venture. Although making it to the final line is definitely worth the effort, not that many reach it. I talked with several experts in founding biotech startups to find out what the most common reasons ... The post Top 5 Reasons Why Biotech Startups Fail appeared first on Labiotech.eu.
A little over 12 months ago, Belgian Nanobody biotech Ablynx was at the center of a bidding war between Novo...
Die Schweizer Biotech-Beteiligungsgesellschaft BB Biotech (WKN: A0NFN3) hat zum Ende der letzten Woche vorläufige Zahlen für die ersten neun Monate des Geschäftsjahres 2018 präsentiert. Obwohl die ...
In the last decade, crowdfunding has become a popular way to finance all sorts of projects and products. Biotech is no exception, but many question whether the high risk and long term nature of investing in the biotech industry makes ... The post Equity Crowdfunding for Biotech Startups: Does it Work? appeared first on Labiotech.eu.
Why are biotech stocks in the dumps? Is the latest in cancer care overhyped? And what does "folie à deux" mean? Find out on the latest episode of our biotech…
Speaking on the sidelines of Biotech Showcase 2019, Dan Gooding, CEO of Nuformix, explains to Mike Ward how the UK...
BB Biotech erweitert den Verwaltungsrat DGAP-Ad-hoc: BB BIOTECH AG / Schlagwort(e): Personalie BB Biotech erweitert den Verwaltungsrat 19.10.2018 / 07:00 CET/CEST Veröffentlichung einer Insiderinf...
Erneuter Dämpfer für Biotech-Investoren: Im Zuge der allgemeinen Marktschwäche trifft es auch diesen Sektor. Im gestrigen Handel verlor der Nasdaq Biotechnology Index 3,52 Prozent auf 3.351 Punkte....
Die Aktie des Schweizer Biotech-Investors BB Biotech hat in diesem Jahr bereits einen rasanten Aufstieg hinter sich bringen können. Angetrieben von Übernahmen wie dem Depot-Wert Celgene wie auch we...